Autologous macrophage transfer is an emerging platform for cell therapy. It is anticipated that conventional macrophage reprogramming based on ex vivo polarization using cytokines and ligands of TLRs may enhance the therapeutic effect. We describe an alternative approach based on small interfering RNA (siRNA) knockdown of selected molecular cues of macrophage polarization. namely EGR2. https://www.jmannino.com/super-super-University-of-Arizona-Primary-Mark-iPhone-14-Plus-MagSafe-Case-p76978-deal-zone/